Royce & Associates LP Schrodinger, Inc. Transaction History

Royce & Associates LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$53.75 - $76.55 $1.95 Million - $2.78 Million	-36,350 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$59.02 - $78.8 $1.53 Million - $2.05 Million	-26,000 Reduced 41.7%	36,350 $2.75 Million
Q1 2021 May 10, 2021	BUY	$64.61 - $113.09 $2.15 Million - $3.77 Million	33,350 Added 115.0%	62,350 $4.76 Million
Q4 2020 Feb 08, 2021	BUY	$48.06 - $84.4 $865,080 - $1.52 Million	18,000 Added 163.64%	29,000 $2.3 Million
Q3 2020 Nov 12, 2020	BUY	$46.87 - $93.33 $515,570 - $1.03 Million	11,000 New	11,000 $523,000

236

61M

726K

329K

Ticker SDGR
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 62,028,400
Market Cap $1.33B
Description
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.